These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30514)

  • 1. Beta-blockers in treatment of hypertension.
    Harris D; Richards DA
    Br Med J; 1978 Sep; 2(6141):894. PubMed ID: 30514
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol for hypertension.
    Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
    [No Abstract]   [Full Text] [Related]  

  • 3. Labetalol in long-term treatment of hypertension.
    Prichard BN; Boakes AJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
    Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
    Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol].
    Gérard J; Blazquez G; Mounac M; Giraud P; Jeuffroy A; Lardoux H
    Rev Fr Gynecol Obstet; 1984 Nov; 79(11):713-7. PubMed ID: 6152500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological basis for the use of labetalol in the treatment of hypertension.
    Prichard BN; Richards DA
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S24-9. PubMed ID: 6169957
    [No Abstract]   [Full Text] [Related]  

  • 7. Labetalol in hypertension.
    Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
    [No Abstract]   [Full Text] [Related]  

  • 8. Labetalol: an alpha- and beta-blocker.
    Conner CS
    Drug Intell Clin Pharm; 1983; 17(7-8):543-4. PubMed ID: 6135593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension: myth or reality? Workshop held in Corsendonck (Belgium) on February 28, 1981.
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-74. PubMed ID: 6169955
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetolol--combined alpha and beta blockade for hypertension.
    Raftery EB
    Scott Med J; 1978 Oct; 23(4):279-80. PubMed ID: 31683
    [No Abstract]   [Full Text] [Related]  

  • 13. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
    Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
    Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
    Hansson L; Hänel B
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol in the treatment of hypertension in general practice.
    Forsell P; O'Sullivan J; Carson N
    Aust Fam Physician; 1979 Nov; 8(11):1165-6. PubMed ID: 393223
    [No Abstract]   [Full Text] [Related]  

  • 17. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
    Hansson L; Hänel B
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
    Eliasson K; Danielson M; Hylander B; Lindblad LE
    Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic long-term effects of labetalol in essential hypertension.
    Lund-Johansen P
    Acta Med Scand Suppl; 1979; 625():54-8. PubMed ID: 285576
    [No Abstract]   [Full Text] [Related]  

  • 20. Labetalol infusion for the treatment of hypertension in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Chamberlain DA
    Eur Heart J; 1980 Dec; 1(6):413-6. PubMed ID: 7274255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.